Andrew Hore – Quoted Micro 1 March 2021

AQUIS STOCK EXCHANGE Incanthera (INC) says that it is prioritising discussions with two global cosmetic companies as potential partners for Sol, a sun cream that prevents skin cancer. Incanthera is also assessing the potential for using the technology to develop other products. Sativa Wellness (SWEL) plans to raise C$4m through a placing of units at […]

Andrew Hore – Quoted Micro 22 June 2020

AQUIS STOCK EXCHANGE Cancer treatment developer Incanthera (INC) had cash of £392,000 at the end of March 2020, following its fundraising when it joined the Aquis Stock Exchange. The company has a call option on more than £350,000 of additional cash. That should fund this year’s requirements and make the company’s cash last until next […]

Andrew Hore: Quoted Micro 29 October 2018

NEX EXCHANGE Auxico Resources Canada Inc (AUAG) has added a NEX quotation to its year-old Canadian Stock Exchange listing. Auxico has mineral properties in Colombia and Mexico. There is already a UK investor base. Chapel Down Group (CDGP) had a bumper 2018 harvest that was 125% ahead of the previous best, thanks to the hot […]

Andrew Hore Quoted Micro 24 September 2018

NEX EXCHANGE        In the first half of 2018, Newbury Racecourse (NYR) increased media revenues by one-fifth and, along with growth in nursery and lodge revenues, this helped the racecourse operator to raise revenues by 5% to £7.33m even though two race days were lost to bad weather. Enough cash was generated to […]

Andrew Hore – Quoted Micro 11 June 2018

NEX EXCHANGE    There are eight companies in the running for the NEX Exchange company of the year at the Small Cap Awards. The awards will be held at The Montcalm Hotel, Marble Arch. Kent-based wines maker Chapel Down Group (CDGP) has built up a significant presence in the English wines market. The company has […]

Andrew Hore – Quoted Micro 19 March 2018

NEX EXCHANGE    Formation Group (FRM) has been repaid its £5m loan for a development in Wembley and it retains a 40% share of the profit of the development. This cash has been used to invest in acquired a 3.44% stake in Proton Partners International, which has an operational proton beam therapy centre in South […]